Mindray was founded in 1991 with the goal of delivering high-quality, competitively priced medical devices to make healthcare more accessible and affordable around the world. In 2006, Mindray listed on the New York Stock Exchange and is now a leading developer, manufacturer and marketer of medical devices worldwide.
The company has three well-established business segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products and Medical Imaging Systems. Health care facilities equipped with Mindray’s products can be found in over 190 countries and regions. A sound distribution and service network has been formed with 31 branch offices throughout China, and overseas subsidiaries in Brazil, Canada, France, Germany, India, Indonesia, Italy, Mexico, Netherlands, Russia, Turkey, the UK and the U.S. , Spain, Egypt , Columbia, Thailand and Vietnam. Additionally, the acquisition of Datascope Corporation's patient monitoring business has added significant direct sales and service capabilities on the ground in the U.S. and Western Europe.
Mindray has a global R&D network with research centers in Shenzhen, Beijing, Nanjing, Shanghai, Chengdu, Xi’an, Seattle, New Jersey, Stockholm and Miami. Approximately 10% of total revenue has been consistently re-invested into R&D each year. An average of eight new products has annually been introduced to the market over the past seven years.